Skip to main content
Premium Trial:

Request an Annual Quote

TessArae, Kindstar Developing Genetic Tests for Chinese Population

NEW YORK (GenomeWeb News) – TessArae and Kindstar Global today announced a collaboration to develop genetic tests for the Chinese population.

The two firms provided no details about the test that would be developed except that they will be pan-ethnic screens for the Chinese population and use TessArae's targeted sequencing development platform and bioanalysis software. The tests will run in Kindstar's laboratories in China.

TessArae's platform combines a multiplexed amplification strategy with an Affymetrix microarray protocol. Results are analyzed by the Potomac Fall, Va.-based company's GeneCipher algorithms.

Kindstar is the largest esoteric reference laboratory in China, TessArae said, providing its services to more than 3,300 hospitals. Last week, it and Illumina said they were collaborating to introduce molecular assays based on Illumina products in Kindstar's laboratories.

TessArae and Kindstar did not disclose the financial terms of their deal.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.